A5035743673- Dementia and Cognitive Impairment Research
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical studies and practices
- Blood Pressure and Hypertension Studies
- Religion, Spirituality, and Psychology
- Healthcare Systems and Technology
- Technology Use by Older Adults
- Cognitive Functions and Memory
- Pharmacovigilance and Adverse Drug Reactions
- Healthcare Systems and Practices
- Nutritional Studies and Diet
- Psychology Research and Bibliometrics
- Grief, Bereavement, and Mental Health
- Intensive Care Unit Cognitive Disorders
- Medication Adherence and Compliance
- Health and Medical Education
- Frailty in Older Adults
- Pharmacy and Medical Practices
- Health, Environment, Cognitive Aging
Universidad Cardenal Herrera CEU
2020-2024
Laboratorios Farmaceúticos Rovi (Spain)
2021
Valencia Catholic University Saint Vincent Martyr
2021
Spanish Society of Family and Community Medicine
2020
Hospital Universitario de Gran Canaria Doctor Negrín
2014-2015
The increase in life expectancy has also been accompanied by an the use of medication to treat chronic diseases. Polypharmacy is associated with medication-related problems such as anticholinergic burden. Older people are more susceptible effects on central nervous system and this, turn, may be related cognitive impairment. In this paper, we develop updated burden scale, CRIDECO Anticholinergic Load Scale (CALS) via a systematic review literature compare it currently most used Burden (ACB)....
Cognitive impairment (CI) is known to be mediated by several risk and protective factors, many of which are potentially modifiable. Therefore, it important have up-to-date studies that address a standard assessment psychosocial, clinical lifestyle variables.We conducted cross-sectional observational study, with 24-month timeframe, estimate the relationship between factors associated dementia, according A-to-Z Dementia Knowledge. Participants were considered at CI if they tested positive for...
The increased pressure on primary care makes it important for other health providers, such as community pharmacists, to collaborate with general practitioners in activities related chronic disease care. Therefore, the objective of present project was develop a protocol action that allows close pharmacist-physician collaboration carry out coordinated very early detection cognitive impairment (CI). Methods: A comparative study promote CI conducted 19 pharmacies divided into two groups: one...
Dementia is a neurodegenerative disease with no cure that can begin up to 20 years before its diagnosis. A key priority in patients dementia the identification of early modifiable factors slow progression disease. Community pharmacies are suitable points for cognitive-impairment screening because their proximity patients. Therefore, continuous training professionals working directly impacts public health population. The main purpose this study was assess community pharmacists’ knowledge...
Subjective memory complaints (SMCs) may be important markers in the prediction of cognitive deterioration. The aim this study was to find associations between individual lifestyle factors, which contribute impairment (CI) people with SMCs and conduct a literature review on relationship internet use CI subjects over 50 years old, as related factor. This case-controlled that included 497 aged who were recruited from 19 community pharmacies. Three screening tests used detect possible CIs,...
Prior to the onset of dementia, individuals commonly undergo a phase marked by subtle cognitive changes, known as decline. Recognizing these early alterations is crucial, they can serve indicators an impending decline in function, warranting timely intervention and support.
<title>Abstract</title> <bold>Purpose: </bold>Early screening for cognitive decline (CD) is crucial managing dementia risk factors and preventing disease progression. This study seeks to create a detailed profile patients who are candidates CD screening, with focus on identifying emerging deficits their underlying causes. <bold>Methods: </bold>We first performed systematic review of practices within community pharmacies. Following this, we analyzed data from 286 individuals were screened...
Subjective cognitive decline (SCD) would correspond to a preclinical phase of Alzheimer's disease. The aim this study was find associations between lifestyle individual factors compatible scores with impairment (CI) in SCD people. Methods: This is case-control detect SCD, CI and potential associated 497 patients over 50 years Community Pharmacies. Three screening tests detected possible at least one test were referred Primary Care be evaluated. Results: In self-complaint statistically...
<h3>Background</h3> Medicines reconciliation studies have produced estimates about rates of patients and drugs involved in unintended discrepancies along the process, but to our knowledge no-one has worked out reasons for these discrepancies. <h3>Purpose</h3> To determine analyse prevalence medicines at Emergency Department (ED), which a Hospital Pharmacist is integrated into multidisciplinary team. find main that justify intended ATC groups mostly <h3>Materials methods</h3> Prospective...
<h3>Background</h3> The administration of an intensive dose statins after acute myocardial infarction (AMI) has proved to be superior conventional doses in reducing morbidity and mortality (IA evidence) but application clinical practice is variable. <h3>Purpose</h3> To find out whether are being used AMI the involvement emergency pharmacist this quality measure. <h3>Material methods</h3> study was conducted from February April 2014 room with a tertiary hospital. Patients were recorded their...